Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and Weight Loss Efficacy of K-757 Alone and in Combination With K-833 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, tolerability, and weight loss efficacy of K-757 alone and in combination with K-833 in obesity has completed. Results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• K-757
• K-833

Snippet

Sponsor: Kallyope Inc. | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2025-02-26